Clinical trial
Immunotherapy of Recurrent Cervical Cancers Using Dendritic Cells (DCs)
NCT00155766 · National Taiwan University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00155766 |
|---|---|
| Title | Immunotherapy of Recurrent Cervical Cancers Using Dendritic Cells (DCs) |
| Official title | A Pilot Study for the Immunotherapy of Recurrent Cervical Cancers Using Dendritic Cells (DCs) Pulsed With Human Papillomavirus Type 16 E7 Antigen |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cervical Cancer |
| Intervention type | Biological |
| Interventions | HPV16 E7 peptide-pulsed autologous DCs |
| Enrollment | 12 |
| Start date | Jan 1, 2003 |
| Completion | Mar 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Dec 20, 2005 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: